Individual responses vary considerably based on baseline weight, rate of weight loss, underlying conditions such as PCOS, and overall metabolic health
Clinical symptoms are numerous including digestive symptoms (nausea, vomiting, anorexia, abdominal pain, and failure to thrive) and neuropsychiatric symptoms (headaches, ataxia, dysarthria, behavioral modifications, neurodevelopmental delay, and hypotonia) and, in severe cases, seizures, alteration of consciousness, and central hyperventilation
However, it is also gaining significant attention for its effectiveness in promoting weight loss
IV therapy carries higher risks of sudden cardiovascular reactions, infection at the injection site, and potential contamination
The dorsogluteal site has been phased out of current guidance because of its proximity to the sciatic nerve and superior gluteal artery
Product features Lyophilized (freeze-dried) formulation designed to support compound stability and extended shelf life